Anna Wardowska
Overview
Explore the profile of Anna Wardowska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makowska M, Wardowska A, Bauer M, Wyrzykowski D, Maluch I, Sikorska E
Bioorg Chem
. 2024 Sep;
153:107821.
PMID: 39293303
Antimicrobial peptides (AMPs) display advantages over traditional antibiotics due to their broad spectrum of activity against various pathogens, and may even overcome bacterial drug resistance. However, despite their potential therapeutic...
2.
Lisowska K, Ciesielska-Figlon K, Komorniczak M, Bullo-Piontecka B, Debska-Slizien A, Wardowska A
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125849
Systemic lupus erythematosus (SLE) patients have an increased risk of infections and infection-related mortality. Therefore, during the global SARS-CoV-2 pandemic, SLE patients were particularly vulnerable to SARS-CoV-2 infections. Also, compared...
3.
Schumacher A, Mucha P, Puchalska I, Deptula M, Wardowska A, Tyminska A, et al.
Biomed Pharmacother
. 2024 Jun;
177:117052.
PMID: 38943988
Adipose-derived mesenchymal stromal cells (AD-MSCs) are an essential issue in modern medicine. Extensive preclinical and clinical studies have shown that mesenchymal stromal/stem cells, including AD-MSCs, have specific properties (ability to...
4.
Wojciechowicz K, Kuncewicz K, Rutkowski J, Jassem J, Wardowska A, Spodzieja M
Front Immunol
. 2024 Jun;
15:1362152.
PMID: 38835768
Introduction: The effector function of T cells is regulated via immune checkpoints, activating or inhibiting the immune response. The BTLA-HVEM complex, the inhibitory immune checkpoint, may act as one of...
5.
Wojciechowicz K, Kuncewicz K, Rutkowski J, Jassem J, Rodziewicz-Motowidlo S, Wardowska A, et al.
Biomed Pharmacother
. 2024 May;
175:116675.
PMID: 38733770
The complex of B- and T-lymphocyte attenuator (BTLA) and herpes virus entry mediator (HVEM) plays a critical role in immune regulation and has emerged as a promising therapeutic target for...
6.
Madej E, Lisek A, Brozyna A, Cierniak A, Wronski N, Deptula M, et al.
J Cancer Res Clin Oncol
. 2024 Apr;
150(4):209.
PMID: 38656555
Purpose: The receptor-interacting protein kinase (RIPK4) has an oncogenic function in melanoma, regulates NF-κB and Wnt/β-catenin pathways, and is sensitive to the BRAF inhibitors: vemurafenib and dabrafenib which lead to...
7.
Wojciechowicz K, Spodzieja M, Wardowska A
Eur J Med Chem
. 2024 Feb;
268:116231.
PMID: 38387336
The BTLA-HVEM complex plays a pivotal role in cancer and cancer immunotherapy by regulating immune responses. Dysregulation of BTLA and HVEM expression contributes to immunosuppression and tumor progression across various...
8.
Wojciechowicz K, Kuncewicz K, Lisowska K, Wardowska A, Spodzieja M
Eur J Pharm Sci
. 2023 Dec;
193:106677.
PMID: 38128840
Immune checkpoints secure the proper function of the immune system and the maintenance of the BTLA-HVEM complex, an inhibitory immune checkpoint, is one of the pathways vital for T cell...
9.
Ciesielska-Figlon K, Wojciechowicz K, Wardowska A, Lisowska K
Antioxidants (Basel)
. 2023 Jul;
12(7).
PMID: 37507880
Background: For thousands of years till nowadays, (NS) has served as a common spice and food preservative. Its seed extracts, seed oil, and essential oil in traditional medicine have been...
10.
Kuncewicz K, Bojko M, Battin C, Karczynska A, Sieradzan A, Sikorska E, et al.
Biomed Pharmacother
. 2023 Jul;
165:115161.
PMID: 37473684
Immune checkpoints can be divided into co-stimulatory and co-inhibitory molecules that regulate the activation and effector functions of T cells. The co-inhibitory pathways mediated by ICPs are used by cancer...